ERBB2 c.2263_2264delinsCC ;(p.L755P)

Variant ID: 17-37880219-TT-CC

NM_004448.2(ERBB2):c.2263_2264delinsCC;(p.L755P)

This variant was identified in 92 publications

View GRCh38 version.




Publications:


Activity of osimertinib in a patient with stage IV non-small cell lung cancer harboring HER2 exon 19, p.L755P mutation: case report.

Translational Lung Cancer Research
Jonsdottir, Gudbjorg G; Smith, Mark M; Wood, Samuel S; Hejleh, Taher Abu TA; Furqan, Muhammad M
Publication Date: 2023-04-28

Variant appearance in text: HER2: L755P
PubMed Link: 37197637
Variant Present in the following documents:
  • tlcr-12-04-927-coif.pdf
View BVdb publication page



Genomic landscape and efficacy of HER2-targeted therapy in patients with HER2-mutant non-small cell lung cancer.

Frontiers In Oncology
Han, Yanjie Y; Xiong, Yuanyuan Y; Lu, Tao T; Chen, Rongrong R; Liu, Yuan Y; Tang, Hui H; Geng, Ruixuan R; Wang, Yingyi Y
Publication Date: 2023

Variant appearance in text: HER2: L755P
PubMed Link: 37077822
Variant Present in the following documents:
  • fonc-13-1121708.pdf
View BVdb publication page



Mechanisms of neratinib resistance in HER2-mutant metastatic breast cancer.

Cancer Drug Resistance (Alhambra, Calif.)
Eli, Lisa D LD; Kavuri, Shyam M SM
Publication Date: 2022

Variant appearance in text: HER2: L755P
PubMed Link: 36627899
Variant Present in the following documents:
  • cdr-5-4-873.pdf
View BVdb publication page



An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy.

Frontiers In Immunology
Lin, Jing J; Liu, Jun J; Hao, Shi-Guang SG; Lan, Bin B; Zheng, Xiao-Bin XB; Xiong, Jia-Ni JN; Zhang, Ying-Qian YQ; Gao, Xuan X; Chen, Chuan-Ben CB; Chen, Ling L; Huang, Yu-Fang YF; Luo, Hong H; Yi, Yu-Ting YT; Yi, Xin X; Lu, Jian-Ping JP; Zheng, Xiong-Wei XW; Chen, Gang G; Wang, Xue-Feng XF; Chen, Yu Y
Publication Date: 2022

Variant appearance in text: ERBB2: 2263_2264delTTinsCC; L755P
PubMed Link: 36505399
Variant Present in the following documents:
  • Table_2.xlsx, sheet 3
  • Table_2.xlsx, sheet 2
View BVdb publication page



Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancer.

Thoracic Cancer
Zhang, Shirong S; Wang, Wenxian W; Xu, Chunwei C; Zhang, Yongchang Y; Cai, Xiuyu X; Wang, Qian Q; Song, Zhengbo Z; Li, Ziming Z; Yu, Jinpu J; Zhong, Wenzhao W; Wang, Zhijie Z; Liu, Jingjing J; Liu, Anwen A; Li, Wen W; Zhan, Ping P; Liu, Hongbing H; Lv, Tangfeng T; Miao, Liyun L; Min, Lingfeng L; Lin, Gen G; Huang, Long L; Yuan, Jingping J; Jiang, Zhansheng Z; Pu, Xingxiang X; Rao, Chuangzhou C; Lv, Dongqing D; Yu, Zongyang Z; Li, Xiaoyan X; Tang, Chuanhao C; Zhou, Chengzhi C; Zhang, Junping J; Guo, Hui H; Chu, Qian Q; Meng, Rui R; Liu, Xuewen X; Wu, Jingxun J; Zhou, Jin J; Zhu, Zhengfei Z; Pan, Weiwei W; Dong, Xiaowei X; Pang, Fei F; Wang, Kai K; Yao, Chao C; Lin, Guomin G; Li, Site S; Yang, Zhi Z; Luo, Jiancheng J; Jia, Hongtao H; Nie, Xiuqing X; Wang, Liping L; Zhu, Youcai Y; Hu, Xiao X; Xie, Yanru Y; Lin, Xinqing X; Cai, Jing J; Xia, Yang Y; Feng, Huijing H; Wang, Lin L; Du, Yingying Y; Yao, Wang W; Shi, Xuefei X; Niu, Xiaomin X; Yuan, Dongmei D; Yao, Yanwen Y; Kang, Jing J; Zhang, Jiatao J; Zhang, Chao C; Gao, Wenbin W; Huang, Jianhui J; Zhang, Yinbin Y; Sun, Pingli P; Wang, Hong H; Ye, Mingxiang M; Wang, Dong D; Wang, Zhaofeng Z; Wan, Bing B; Lv, Donglai D; Yu, Genhua G; Shi, Lin L; Xia, Yuanli Y; Gao, Feng F; Zhang, Xiaochen X; Xu, Tao T; Zhou, Wei W; Wang, Haixia H; Liu, Zhefeng Z; Yang, Nong N; Wu, Lin L; Wang, Qiming Q; Wang, Guansong G; Hong, Zhuan Z; Wang, Jiandong J; Fang, Meiyu M; Fang, Yong Y; Zhang, Yiping Y; Song, Yong Y; Ma, Shenglin S; Fang, Wenfeng W; Lu, Yuanzhi Y
Publication Date: 2022-11-28

Variant appearance in text: HER2: L755P
PubMed Link: 36444143
Variant Present in the following documents:
  • Main text
  • TCA-14-91.pdf
View BVdb publication page



Real World Characteristics and Clinical Outcomes of HER2-Mutant Non-Small Cell Lung Cancer Patients Detected by Next-Generation Sequencing.

Cancer Research And Treatment
Ahn, Beung-Chul BC; Han, Ye-Jeong YJ; Kim, Hye Ryun HR; Hong, Min Hee MH; Cho, Byoung Chul BC; Lim, Sun Min SM
Publication Date: 2022-11-09

Variant appearance in text: HER2: L755P
PubMed Link: 36397236
Variant Present in the following documents:
  • Main text
  • crt-2022-359.pdf
View BVdb publication page



Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches.

Journal Of Personalized Medicine
Bontoux, Christophe C; Benzaquen, Jonathan J; Hofman, Véronique V; Heeke, Simon S; Hannetel, Paul P; Capela-Brosseau-Laborde, Pierre P; Marquette, Charles-Hugo CH; Ilié, Marius M; Hofman, Paul P
Publication Date: 2022-10-04

Variant appearance in text: HER2: L755P
PubMed Link: 36294789
Variant Present in the following documents:
  • Main text
  • jpm-12-01651.pdf
View BVdb publication page



Molecular Landscape of ERBB2 Alterations in 14,956 Solid Tumors.

Pathology Oncology Research : Por
Wang, Hao H; Miao, Ji J; Wen, Yazhou Y; Xia, Xihua X; Chen, Yanan Y; Huang, Mengli M; Chen, Shiqing S; Zhao, Zhengyi Z; Zhang, Yuzi Y; Chen, Chunzhu C; Zhu, Xinhua X
Publication Date: 2022

Variant appearance in text: ERBB2: L755P
PubMed Link: 35911441
Variant Present in the following documents:
  • Main text
  • pore-28-1610360.pdf
View BVdb publication page



Increased blood-based intratumor heterogeneity (bITH) is associated with unfavorable outcomes of immune checkpoint inhibitors plus chemotherapy in non-small cell lung cancer.

Bmc Medicine
Zhou, Juan J; Bao, Minwei M; Gao, Guanghui G; Cai, Yiran Y; Wu, Lihong L; Lei, Lei L; Zhao, Jing J; Ji, Xianxiu X; Huang, Ying Y; Su, Chunxia C
Publication Date: 2022-07-29

Variant appearance in text: ERBB2: L755P
PubMed Link: 35902848
Variant Present in the following documents:
  • 12916_2022_2444_MOESM1_ESM.xlsx, sheet 4
View BVdb publication page



Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers.

Aging
Su, Xiaofan X; Jin, Haoxuan H; Wang, Jiaqian J; Lu, Huiping H; Gu, Tiantian T; Gao, Zhibo Z; Li, Manxiang M
Publication Date: 2022-05-25

Variant appearance in text: ERBB2: 2263_2264delTTinsCC; L755P
PubMed Link: 35613927
Variant Present in the following documents:
  • aging-14-204101-s004.xlsx, sheet 1
View BVdb publication page



Understanding the activating mechanism of the immune system against COVID-19 by Traditional Indian Medicine: Network pharmacology approach.

Advances In Protein Chemistry And Structural Biology
Thirumal Kumar, D D; Shree Devi, M S MS; Udhaya Kumar, S S; Sherlin, Annie A; Mathew, Aishwarya A; Lakshmipriya, M M; Sathiyarajeswaran, P P; Gnanasambandan, R R; Siva, R R; Magesh, R R; George Priya Doss, C C
Publication Date: 2022

Variant appearance in text: ERBB2: L755P
PubMed Link: 35305722
Variant Present in the following documents:
  • mmc09-01-9780323992275.pdf
View BVdb publication page



Clinical and genomic features of Chinese lung cancer patients with germline mutations.

Nature Communications
Peng, Wenying W; Li, Bin B; Li, Jin J; Chang, Lianpeng L; Bai, Jing J; Yi, Yuting Y; Chen, Rongrong R; Zhang, Yanyan Y; Chen, Chen C; Pu, Xingxiang X; Jiang, Meilin M; Li, Jia J; Zhong, Rui R; Xu, Fang F; Chen, Bolin B; Xu, Li L; Wang, Ning N; Huan, Jiaojiao J; Dai, Pingping P; Guan, Yanfang Y; Yang, Ling L; Xia, Xuefeng X; Yi, Xin X; Wang, Jiayin J; Yu, Fenglei F; Wu, Lin L
Publication Date: 2022-03-10

Variant appearance in text: ERBB2: 2263_2264delTTinsCC; L755P
PubMed Link: 35273153
Variant Present in the following documents:
  • 41467_2022_28840_MOESM7_ESM.xlsx, sheet 1
View BVdb publication page



The efficacy of afatinib in patients with HER2 mutant non-small cell lung cancer: a meta-analysis.

Translational Cancer Research
Zhou, Niya N; Zhao, Jie J; Huang, Xiu X; Shen, Hui H; Li, Wen W; Xu, Zhihao Z; Xia, Yang Y
Publication Date: 2020-05

Variant appearance in text: HER2: L755P
PubMed Link: 35117726
Variant Present in the following documents:
  • Main text
  • tcr-09-05-3634.pdf
View BVdb publication page



KLF3 and PAX6 are candidate driver genes in late-stage, MSI-hypermutated endometrioid endometrial carcinomas.

Plos One
Rudd, Meghan L ML; Hansen, Nancy F NF; Zhang, Xiaolu X; Urick, Mary Ellen ME; Zhang, Suiyuan S; Merino, Maria J MJ; , ; Mullikin, James C JC; Brody, Lawrence C LC; Bell, Daphne W DW
Publication Date: 2022

Variant appearance in text: rs121913469
PubMed Link: 35081118
Variant Present in the following documents:
  • pone.0251286.s005.xlsx, sheet 8
View BVdb publication page



KLF3 and PAX6 are candidate driver genes in late-stage, MSI-hypermutated endometrioid endometrial carcinomas.

Plos One
Rudd, Meghan L ML; Hansen, Nancy F NF; Zhang, Xiaolu X; Urick, Mary Ellen ME; Zhang, Suiyuan S; Merino, Maria J MJ; , ; Mullikin, James C JC; Brody, Lawrence C LC; Bell, Daphne W DW
Publication Date: 2022

Variant appearance in text: rs121913469
PubMed Link: 35081118
Variant Present in the following documents:
  • pone.0251286.s005.xlsx, sheet 8
View BVdb publication page



HER2 Aberrations in Non-Small Cell Lung Cancer: From Pathophysiology to Targeted Therapy.

Pharmaceuticals (Basel, Switzerland)
Vathiotis, Ioannis A IA; Charpidou, Andriani A; Gavrielatou, Niki N; Syrigos, Konstantinos N KN
Publication Date: 2021-12-14

Variant appearance in text: HER2: L755P
PubMed Link: 34959700
Variant Present in the following documents:
  • Main text
  • pharmaceuticals-14-01300.pdf
View BVdb publication page



HER2 Aberrations in Non-Small Cell Lung Cancer: From Pathophysiology to Targeted Therapy.

Pharmaceuticals (Basel, Switzerland)
Vathiotis, Ioannis A IA; Charpidou, Andriani A; Gavrielatou, Niki N; Syrigos, Konstantinos N KN
Publication Date: 2021-12-14

Variant appearance in text: HER2: L755P
PubMed Link: 34959700
Variant Present in the following documents:
  • Main text
  • pharmaceuticals-14-01300.pdf
View BVdb publication page



Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.

Journal For Immunotherapy Of Cancer
Hu, Chunhong C; Zhao, Lishu L; Liu, Wenliang W; Fan, Songqing S; Liu, Junqi J; Liu, Yuxuan Y; Liu, Xiaohan X; Shu, Long L; Liu, Xianling X; Liu, Ping P; Deng, Chao C; Qiu, Zhenhua Z; Chen, Chen C; Jiang, Yi Y; Liang, Qingchun Q; Yang, Lingling L; Shao, Yang Y; He, Qiongzhi Q; Yu, Danlei D; Zeng, Yue Y; Li, Yizheng Y; Pan, Yue Y; Zhang, Sujuan S; Shi, Shenghao S; Peng, Yurong Y; Wu, Fang F
Publication Date: 2021-12

Variant appearance in text: ERBB2: L755P
PubMed Link: 34887263
Variant Present in the following documents:
  • jitc-2021-003773supp001.pdf
View BVdb publication page



Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial.

Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology
Le, Xiuning X; Cornelissen, Robin R; Garassino, Marina M; Clarke, Jeffrey M JM; Tchekmedyian, Nishan N; Goldman, Jonathan W JW; Leu, Szu-Yun SY; Bhat, Gajanan G; Lebel, Francois F; Heymach, John V JV; Socinski, Mark A MA
Publication Date: 2022-03-01

Variant appearance in text: HER2: L755P
PubMed Link: 34843401
Variant Present in the following documents:
  • Main text
  • jco-40-710.pdf
View BVdb publication page



Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology
Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C
Publication Date: 2021

Variant appearance in text: ERBB2: L755P
PubMed Link: 34630336
Variant Present in the following documents:
  • Table_1.xlsx, sheet 2
View BVdb publication page



Activity and mechanism of acquired resistance to tarloxotinib in HER2 mutant lung cancer: an in vitro study.

Translational Lung Cancer Research
Koga, Takamasa T; Suda, Kenichi K; Nishino, Masaya M; Fujino, Toshio T; Ohara, Shuta S; Hamada, Akira A; Soh, Junichi J; Tirunagaru, Vijaya V; Vellanki, Avanish A; Doebele, Robert C RC; Mitsudomi, Tetsuya T
Publication Date: 2021-08

Variant appearance in text: HER2: L755P
PubMed Link: 34584864
Variant Present in the following documents:
  • Main text
  • tlcr-10-08-3659-supplementary.pdf
  • tlcr-10-08-3659.pdf
View BVdb publication page



Targeting HER2 in non-small-cell lung cancer (NSCLC): a glimpse of hope? An updated review on therapeutic strategies in NSCLC harbouring HER2 alterations.

Esmo Open
Riudavets, M M; Sullivan, I I; Abdayem, P P; Planchard, D D
Publication Date: 2021-10

Variant appearance in text: HER2: L755P
PubMed Link: 34479034
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Saura, Cristina C; Matito, Judit J; Oliveira, Mafalda M; Wildiers, Hans H; Brufksy, Adam M AM; Waters, Simon H SH; Hurvitz, Sara A SA; Moy, Beverly B; Kim, Sung-Bae SB; Gradishar, William J WJ; Queiroz, Geraldo Silva GS; Cronemberger, Eduardo E; Wallweber, Gerald J GJ; Bebchuk, Judith J; Keyvanjah, Kiana K; Lalani, Alshad S AS; Bryce, Richard R; Vivancos, Ana A; Eli, Lisa D LD; Delaloge, Suzette S
Publication Date: 2021-11-01

Variant appearance in text: HER2: L755P
PubMed Link: 34380637
Variant Present in the following documents:
  • 5818.pdf
View BVdb publication page



Progress in Treatment of Non-Small Cell Lung Cancer Harboring HER2 Aberrations.

Oncotargets And Therapy
Ni, Jun J; Zhang, Li L
Publication Date: 2021

Variant appearance in text: HER2: L755P
PubMed Link: 34262294
Variant Present in the following documents:
  • Main text
  • ott-14-4087.pdf
View BVdb publication page



Integrated Analysis of Genomic and Immunological Features in Lung Adenocarcinoma With Micropapillary Component.

Frontiers In Oncology
Zhang, Shirong S; Xu, Yang Y; Zhao, Pan P; Bao, Hua H; Wang, Xiyong X; Liu, Rui R; Xu, Rujun R; Xiang, Jingjing J; Jiang, Hong H; Yan, Junrong J; Wu, Xue X; Shao, Yang Y; Liang, Jiafeng J; Wu, Qiong Q; Zhang, Zhihao Z; Lu, Shun S; Ma, Shenglin S
Publication Date: 2021

Variant appearance in text: ERBB2: 2263_2264delTTinsCC; L755P
PubMed Link: 34221970
Variant Present in the following documents:
  • Table_3.xlsx, sheet 1
View BVdb publication page



Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-Positive Mammary Carcinoma.

Pharmaceutics
Gameiro, Andreia A; Almeida, Filipe F; Nascimento, Catarina C; Correia, Jorge J; Ferreira, Fernando F
Publication Date: 2021-03-06

Variant appearance in text: HER2: L755P
PubMed Link: 33800900
Variant Present in the following documents:
  • Main text
  • pharmaceutics-13-00346.pdf
View BVdb publication page



Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations.

Translational Lung Cancer Research
Yang, Shuo S; Wang, Yan Y; Zhao, Chao C; Li, Xuefei X; Liu, Qian Q; Mao, Shiqi S; Liu, Yiwei Y; Yu, Xiaofei X; Wang, Wanying W; Tian, Qinrun Q; Pan, Yingying Y; Xiong, Anwen A; Chen, Bin B; Gao, Guanghui G; Li, Wei W; He, Yayi Y; Wu, Fengying F; Chen, Xiaoxia X; Su, Chunxia C; Ren, Shengxiang S; Zhou, Caicun C
Publication Date: 2021-02

Variant appearance in text: HER2: L755P
PubMed Link: 33718019
Variant Present in the following documents:
  • Main text
View BVdb publication page



Mutation profile and immunoscore signature in thymic carcinomas: An exploratory study and review of the literature.

Thoracic Cancer
Asselta, Rosanna R; Di Tommaso, Luca L; Perrino, Matteo M; Destro, Annarita A; Giordano, Laura L; Cardamone, Giulia G; Rubino, Luca L; Santoro, Armando A; Duga, Stefano S; Zucali, Paolo Andrea PA
Publication Date: 2021-05

Variant appearance in text: ERBB2: L755P
PubMed Link: 33704917
Variant Present in the following documents:
  • TCA-12-1271-s003.xls, sheet 1
View BVdb publication page



Enhanced humoral immunity in breast cancer patients with high serum concentration of anti-HER2 autoantibody.

Cancer Medicine
Sato, Yasufumi Y; Shimoda, Masafumi M; Sota, Yoshiaki Y; Miyake, Tomohiro T; Tanei, Tomonori T; Kagara, Naofumi N; Naoi, Yasuto Y; Kim, Seung Jin SJ; Noguchi, Shinzaburo S; Shimazu, Kenzo K
Publication Date: 2021-02

Variant appearance in text: HER2: L755P
PubMed Link: 33506656
Variant Present in the following documents:
  • CAM4-10-1418.pdf
View BVdb publication page



Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients.

Nature Communications
Zhang, Yongliang Y; Yao, Yu Y; Xu, Yaping Y; Li, Lifeng L; Gong, Yan Y; Zhang, Kai K; Zhang, Meng M; Guan, Yanfang Y; Chang, Lianpeng L; Xia, Xuefeng X; Li, Lin L; Jia, Shuqin S; Zeng, Qiang Q
Publication Date: 2021-01-04

Variant appearance in text: ERBB2: 2263_2264delTTinsCC; L755P
PubMed Link: 33397889
Variant Present in the following documents:
  • 41467_2020_20162_MOESM6_ESM.xlsx, sheet 1
  • 41467_2020_20162_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



[Research Progress of Targeted Therapy for HER2 Gene 
in Advanced Non-small Cell Lung Cancer].

Zhongguo Fei Ai Za Zhi = Chinese Journal Of Lung Cancer
Kong, Lingping L; Zhong, Diansheng D
Publication Date: 2020-12-20

Variant appearance in text: HER2: L755P
PubMed Link: 33357319
Variant Present in the following documents:
  • Main text
  • zgfazz-23-12-1108.pdf
View BVdb publication page



Usefulness of a novel device to divide core needle biopsy specimens in a spatially matched fashion.

Scientific Reports
Shiraishi, Takumi T; Inui, Shogo S; Inoue, Yuta Y; Saito, Yumiko Y; Taga, Hideto H; Kaneko, Masatomo M; Tsuji, Keisuke K; Ueda, Saya S; Ueda, Takashi T; Matsugasumi, Toru T; Taniguchi, Hidefumi H; Ueno, Akihisa A; Yamada, Takeshi T; Yamada, Yasuhiro Y; Iwata, Tsuyoshi T; Fujihara, Atsuko A; Hongo, Fumiya F; Ukimura, Osamu O
Publication Date: 2020-10-13

Variant appearance in text: rs121913469
PubMed Link: 33051506
Variant Present in the following documents:
  • 41598_2020_74136_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials.

Jco Precision Oncology
Exman, Pedro P; Garrido-Castro, Ana C AC; Hughes, Melissa E ME; Freedman, Rachel A RA; Li, Tianyu T; Trippa, Lorenzo L; Bychkovsky, Brittany L BL; Barroso-Sousa, Romualdo R; Di Lascio, Simona S; Mackichan, Colin C; Lloyd, Max R MR; Krevalin, Max M; Cerami, Ethan E; Merrill, Margaret S MS; Santiago, Rebecca R; Crowley, Lindsey L; Kuhnly, Nicole N; Files, Janet J; Lindeman, Neal I NI; MacConaill, Laura E LE; Kumari, Priti P; Tolaney, Sara M SM; Krop, Ian E IE; Bose, Ron R; Johnson, Bruce E BE; Ma, Cynthia X CX; Dillon, Deborah A DA; Winer, Eric P EP; Wagle, Nikhil N; Lin, Nancy U NU
Publication Date: 2019

Variant appearance in text: ERBB2: L755P
PubMed Link: 32923853
Variant Present in the following documents:
  • Main text
View BVdb publication page



HER2 Exon 20 Insertion Mutations in Lung Adenocarcinoma: Case Series and Response to Pyrotinib.

Frontiers In Oncology
Zhang, Xinyong X; Lv, Jialin J; Wu, Yuhua Y; Qin, Na N; Ma, Li L; Li, Xi X; Nong, Jingying J; Zhang, Hui H; Zhang, Quan Q; Yang, Xinjie X; Shi, Huibo H; Wang, Jinghui J; Zhang, Shucai S
Publication Date: 2020

Variant appearance in text: HER2: L755P
PubMed Link: 32850330
Variant Present in the following documents:
  • Main text
View BVdb publication page



Oncogenic mutations within the β3-αC loop of EGFR/ERBB2/BRAF/MAP2K1 predict response to therapies.

Molecular Genetics & Genomic Medicine
Zhang, Biao B; Chen, Yongsheng Y; Dai, Pingping P; Yu, Haoda H; Ma, Jianhui J; Chen, Chen C; Zhang, Yan Y; Guan, Yanfang Y; Chen, Rongrong R; Liu, Tao T; Wang, Jiayin J; Yang, Ling L; Yi, Xin X; Xia, Xuefeng X; Ma, Haitao H
Publication Date: 2020-10

Variant appearance in text: ERBB2: L755P
PubMed Link: 32757330
Variant Present in the following documents:
  • Main text
View BVdb publication page



ErBb Family Proteins in Cholangiocarcinoma and Clinical Implications.

Journal Of Clinical Medicine
Jin, Wook W
Publication Date: 2020-07-16

Variant appearance in text: ERBB2: L755P
PubMed Link: 32708604
Variant Present in the following documents:
  • Main text
  • jcm-09-02255.pdf
View BVdb publication page



Real world data analysis of next generation sequencing and protein expression in metastatic breast cancer patients.

Scientific Reports
Hempel, Dirk D; Ebner, Florian F; Garg, Arun A; Trepotec, Zeljka Z; Both, Armin A; Stein, Werner W; Gaumann, Andreas A; Güttler, Lucia L; Janni, Wolfgang W; DeGregorio, Amelie A; Hempel, Louisa L; Milani, Valeria V
Publication Date: 2020-06-26

Variant appearance in text: ERBB2: L755P
PubMed Link: 32591580
Variant Present in the following documents:
  • Main text
  • 41598_2020_Article_67393.pdf
View BVdb publication page



ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia.

Leukemia
Joshi, Sunil K SK; Keck, Jamie M JM; Eide, Christopher A CA; Bottomly, Daniel D; Traer, Elie E; Tyner, Jeffrey W JW; McWeeney, Shannon K SK; Tognon, Cristina E CE; Druker, Brian J BJ
Publication Date: 2020-10

Variant appearance in text: ERBB2: L755P
PubMed Link: 32366937
Variant Present in the following documents:
  • Main text
View BVdb publication page



Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases.

Cancer
Mack, Philip C PC; Banks, Kimberly C KC; Espenschied, Carin R CR; Burich, Rebekah A RA; Zill, Oliver A OA; Lee, Christine E CE; Riess, Jonathan W JW; Mortimer, Stefanie A SA; Talasaz, AmirAli A; Lanman, Richard B RB; Gandara, David R DR
Publication Date: 2020-07-15

Variant appearance in text: ERBB2: L755P
PubMed Link: 32365229
Variant Present in the following documents:
  • Main text
View BVdb publication page



Mutational landscape and characteristics of ERBB2 in non-small cell lung cancer.

Thoracic Cancer
Wei, Xue-Wu XW; Gao, Xin X; Zhang, Xu-Chao XC; Yang, Jin-Ji JJ; Chen, Zhi-Hong ZH; Wu, Yi-Long YL; Zhou, Qing Q
Publication Date: 2020-06

Variant appearance in text: ERBB2: L755P
PubMed Link: 32291971
Variant Present in the following documents:
  • Main text
  • TCA-11-1512.pdf
View BVdb publication page



HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers.

Cancer Discovery
Li, Bob T BT; Michelini, Flavia F; Misale, Sandra S; Cocco, Emiliano E; Baldino, Laura L; Cai, Yanyan Y; Shifman, Sophie S; Tu, Hai-Yan HY; Myers, Mackenzie L ML; Xu, Chongrui C; Mattar, Marissa M; Khodos, Inna I; Little, Megan M; Qeriqi, Besnik B; Weitsman, Gregory G; Wilhem, Clare J CJ; Lalani, Alshad S AS; Diala, Irmina I; Freedman, Rachel A RA; Lin, Nancy U NU; Solit, David B DB; Berger, Michael F MF; Barber, Paul R PR; Ng, Tony T; Offin, Michael M; Isbell, James M JM; Jones, David R DR; Yu, Helena A HA; Thyparambil, Sheeno S; Liao, Wei-Li WL; Bhalkikar, Anuja A; Cecchi, Fabiola F; Hyman, David M DM; Lewis, Jason S JS; Buonocore, Darren J DJ; Ho, Alan L AL; Makker, Vicky V; Reis-Filho, Jorge S JS; Razavi, Pedram P; Arcila, Maria E ME; Kris, Mark G MG; Poirier, John T JT; Shen, Ronglai R; Tsurutani, Junji J; Ulaner, Gary A GA; de Stanchina, Elisa E; Rosen, Neal N; Rudin, Charles M CM; Scaltriti, Maurizio M
Publication Date: 2020-05

Variant appearance in text: HER2: L755P
PubMed Link: 32213539
Variant Present in the following documents:
  • Main text
View BVdb publication page



Mutation Variants and Co-Mutations as Genomic Modifiers of Response to Afatinib in HER2-Mutant Lung Adenocarcinoma.

The Oncologist
Fang, Wenfeng W; Zhao, Shen S; Liang, Ying Y; Yang, Yunpeng Y; Yang, Lin L; Dong, Xiaorong X; Zhang, Li L; Tang, Yong Y; Wang, Shoufeng S; Yang, Yang Y; Ma, Xiaoyan X; Wang, Minghui M; Wang, Wenjing W; Zhao, Songhui S; Wang, Kai K; Gao, Song S; Zhang, Li L
Publication Date: 2020-03

Variant appearance in text: HER2: L755P
PubMed Link: 32162827
Variant Present in the following documents:
  • Main text
View BVdb publication page



Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.

Gastric Cancer : Official Journal Of The International Gastric Cancer Association And The Japanese Gastric Cancer Association
Hescheler, Daniel A DA; Plum, Patrick S PS; Zander, Thomas T; Quaas, Alexander A; Korenkov, Michael M; Gassa, Asmae A; Michel, Maximilian M; Bruns, Christiane J CJ; Alakus, Hakan H
Publication Date: 2020-07

Variant appearance in text: ERBB2: L755P
PubMed Link: 32107691
Variant Present in the following documents:
  • 10120_2020_1045_MOESM1_ESM.xlsx, sheet 12
View BVdb publication page



Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations.

Bmc Cancer
Ruiz-Cordero, Roberto R; Ma, Junsheng J; Khanna, Abha A; Lyons, Genevieve G; Rinsurongkawong, Waree W; Bassett, Roland R; Guo, Ming M; Routbort, Mark J MJ; Zhang, Jianjun J; Skoulidis, Ferdinandos F; Heymach, John J; Roarty, Emily B EB; Tang, Zhenya Z; Medeiros, L Jeffrey LJ; Patel, Keyur P KP; Luthra, Rajyalakshmi R; Roy-Chowdhuri, Sinchita S
Publication Date: 2020-01-31

Variant appearance in text: ERBB2: L755P
PubMed Link: 32005111
Variant Present in the following documents:
  • 12885_2020_6579_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



In the literature: December 2019.

Esmo Open
Gambardella, Valentina V; Insa, Amelia A; Cejalvo, Juan-Miguel JM; Cervantes, Andrés A
Publication Date: 2020-01

Variant appearance in text: ERBB2: L755P
PubMed Link: 31958287
Variant Present in the following documents:
  • Main text
  • esmoopen-2019-000642.pdf
View BVdb publication page



Identification of an Activating Mutation in the Extracellular Domain of HER2 Conferring Resistance to Pertuzumab.

Oncotargets And Therapy
Zhang, Ying Y; Wu, Shanshan S; Zhuang, Xinlei X; Weng, Gaoqi G; Fan, Jiansheng J; Yang, Xiaoyue X; Xu, Yingchun Y; Pan, Liqiang L; Hou, Tingjun T; Zhou, Zhan Z; Chen, Shuqing S
Publication Date: 2019

Variant appearance in text: HER2: L755P
PubMed Link: 31920346
Variant Present in the following documents:
  • Main text
View BVdb publication page



Response to Afatinib in a Patient with Non-Small Cell Lung Cancer Harboring HER2 R896G Mutation: A Case Report.

Oncotargets And Therapy
Lin, Ling L; Ge, Hongfei H; Yan, Zhengqing Z; Wang, Guoqiang G; Wu, Xiaomai X; Lv, Dongqing D
Publication Date: 2019

Variant appearance in text: HER2: L755P
PubMed Link: 31849493
Variant Present in the following documents:
  • Main text
  • ott-12-10897.pdf
View BVdb publication page



Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity.

Cancer Cell
Robichaux, Jacqulyne P JP; Elamin, Yasir Y YY; Vijayan, R S K RSK; Nilsson, Monique B MB; Hu, Lemei L; He, Junqin J; Zhang, Fahao F; Pisegna, Marlese M; Poteete, Alissa A; Sun, Huiying H; Li, Shuai S; Chen, Ting T; Han, Han H; Negrao, Marcelo Vailati MV; Ahnert, Jordi Rodon JR; Diao, Lixia L; Wang, Jing J; Le, Xiuning X; Meric-Bernstam, Funda F; Routbort, Mark M; Roeck, Brent B; Yang, Zane Z; Raymond, Victoria M VM; Lanman, Richard B RB; Frampton, Garrett M GM; Miller, Vincent A VA; Schrock, Alexa B AB; Albacker, Lee A LA; Wong, Kwok-Kin KK; Cross, Jason B JB; Heymach, John V JV
Publication Date: 2019-10-14

Variant appearance in text: ERBB2: L755P
PubMed Link: 31588020
Variant Present in the following documents:
  • Main text
View BVdb publication page



Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical Implementation.

Cancers
Fernandes, Maria Gabriela O MGO; Jacob, Maria M; Martins, Natália N; Moura, Conceição Souto CS; Guimarães, Susana S; Reis, Joana Pereira JP; Justino, Ana A; Pina, Maria João MJ; Cirnes, Luís L; Sousa, Catarina C; Pinto, Josué J; Marques, José Agostinho JA; Machado, José Carlos JC; Hespanhol, Venceslau V; Costa, José Luis JL
Publication Date: 2019-08-22

Variant appearance in text: ERBB2: Leu755Pro
PubMed Link: 31443496
Variant Present in the following documents:
  • cancers-11-01229-s001.pdf
View BVdb publication page



Molecular features of lung adenocarcinoma in young patients.

Bmc Cancer
Chen, Zhen Z; Teng, Xiao X; Zhang, Jing J; Huang, Ke K; Shen, Qian Q; Cao, He H; Luo, Huisong H; Yuan, Yanting Y; Teng, Xiaodong X
Publication Date: 2019-08-06

Variant appearance in text: ERBB2: L755P
PubMed Link: 31387567
Variant Present in the following documents:
  • Main text
  • 12885_2019_Article_5978.pdf
View BVdb publication page



Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and HER2-Mutated Breast Cancer.

Cancers
Collins, Denis M DM; Conlon, Neil T NT; Kannan, Srinivasaraghavan S; Verma, Chandra S CS; Eli, Lisa D LD; Lalani, Alshad S AS; Crown, John J
Publication Date: 2019-05-28

Variant appearance in text: HER2: L755P
PubMed Link: 31141894
Variant Present in the following documents:
  • cancers-11-00737.pdf
View BVdb publication page